GlobeNewswire Inc | Jul 20, 2021 04:01PM EDT

July 20, 2021

HAMILTON, Bermuda, July 20, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) announced today that it will host a conference call and live webcast on Tuesday, August 3, 2021 at 8:30 a.m. Eastern Time to report its second quarter 2021 financial results and recent corporate and portfolio activity.

A live webcast will be accessible through the Investors & Media section of the companys website at www.kiniksa.com. A replay of the webcast will be available on Kiniksas website for 14 days following the conference. The conference call can be accessed by dialing (866) 614-0636 (U.S.andCanada) or (409) 231-2053 (international) using conference ID number 1485623.

About KiniksaKiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. Kiniksas portfolio of assets, ARCALYST (rilonacept), mavrilimumab, vixarelimab and KPL-404, are based on strong biologic rationale or validated mechanisms, target underserved conditions and offer the potential for differentiation. These assets are designed to modulate immunological pathways across a spectrum of diseases. For more information, please visitwww.kiniksa.com.

ARCALYSTis a registered trademark ofRegeneron Pharmaceuticals,Inc.

Every Second Counts!?

Kiniksa Investor and Media Contact Rachel Frank(339) 970-9437rfrank@kiniksa.com